Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease
Clinical trial NCT03867253 · COMPLETED
Trial details
- NCT number
- NCT03867253
- Sponsor
- Oryzon Genomics S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2020-11-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.